Huxley SANSA Home Sleep Apnea Test (1000-00)

by Huxley Medical  · Based in United States →Streamlining cardiosleep diagnosis straight from the chest.
Cardiology Pulmonology Sleep Medicine

Contact for pricing
Regulatory Status Disclosed

Overview

The Huxley SANSA Home Sleep Apnea Test (1000-00) is an innovative, FDA-cleared wearable patch designed to simplify and enhance the diagnosis of sleep-related breathing disorders, particularly Obstructive Sleep Apnea (OSA), and comorbid cardiac arrhythmias. This single-point-of-skin-contact device eliminates the need for cumbersome wires, belts, or hoses, offering an app-free workflow with built-in cellular data upload for seamless transmission of results to healthcare providers.

SANSA utilizes advanced signal processing and AI-powered auto-scoring algorithms to analyze nine physiological data channels, including blood oxygen saturation (SpO2), ECG-derived heart rate, respiratory effort, chest movement, sleep staging (sleep/wake), snoring, body position, and actigraphy. It provides comprehensive insights into sleep health and cardiac rhythms, enabling physicians to make more informed diagnoses and treatment plans.

Validated in multi-site clinical trials, SANSA has demonstrated high accuracy, sensitivity, and specificity comparable to in-laboratory polysomnography (PSG) for detecting mild, moderate, and severe OSA. The device is intended for clinical and home use under the direction of a Healthcare Professional (HCP) and is available by prescription only.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Wearable chest patch design
  • App-free workflow
  • Built-in cellular data upload
  • AI-powered auto-scoring algorithms
  • 9 physiological data channels (ECG, SpO2, Heart Rate, Respiratory Effort, Chest Movement, Body Position, Actigraphy, Snoring, Sleep/Wake Staging)
  • Multi-day monitoring capability
  • Comfortable and non-invasive
  • Validated against polysomnography (PSG)
  • Streamlined diagnostic process for HCPs
  • Secure end-to-end encryption

Use Cases

  • Diagnosis of Obstructive Sleep Apnea (OSA)
  • Detection of cardiac arrhythmias (e.g., atrial fibrillation) during sleep
  • Remote patient monitoring for sleep and cardiac health
  • Streamlining diagnostic workflows for sleep and cardiology practices
  • Reducing patient referral processes and clinic visits
  • Improving access to sleep apnea diagnosis

What Physicians Need to Know

ECG/EKG Analysis Capability
The Huxley SANSA device includes a single-lead ECG sensor, providing an EKG reference channel to record electrical signals from the heart. It has received FDA clearance to function as a diagnostic ECG monitor, offering insight into cardiac arrhythmias such as atrial fibrillation during home sleep testing. The ECG data is recorded and stored for manual annotation and analysis by a healthcare professional.
Arrhythmia Detection Accuracy
The SANSA device is cleared to provide diagnostic insight into cardiac arrhythmias, including atrial fibrillation, during home sleep testing. It aims to restore the electrocardiographic (ECG) assessment often absent in traditional home sleep apnea tests, providing actionable ECG strips for clinician review.
Heart Failure Risk Prediction
The device has the potential to measure hemodynamic parameters associated with heart failure progression, contributing to its multi-diagnostic capabilities in assessing cardiovascular comorbidities alongside sleep apnea.
Cardiac Monitoring Integration
The SANSA is a single chest-worn patch that integrates a single-lead ECG sensor with comprehensive sleep apnea diagnostics. It measures eight to nine physiological channels, including blood oxygen saturation, EKG-derived heart rate, respiratory effort, chest movement, sleep staging, snoring, body position, and actigraphy.
AHA/ACC Guideline Alignment
The device's capability to provide cardiac insights and detect arrhythmias during sleep apnea testing aligns with the focus of cardiologists and electrophysiologists on addressing modifiable risk factors like sleep apnea to optimize patient outcomes and enable guideline-directed care. Its clinical performance for OSA detection was validated against polysomnography (PSG) signals acquired in accordance with the AASM Manual for the Scoring of Sleep and Associated Events.
Real-Time Alert Capability
The SANSA device features cellular data upload, enabling seamless and near real-time transmission of test results to healthcare providers. This eliminates the need for Bluetooth pairing or smartphone apps, ensuring data collection efficiency and facilitating timely physician review.
Physician Tip

The Huxley SANSA Home Sleep Apnea Test offers a unique advantage by combining sleep apnea diagnosis with diagnostic ECG monitoring for arrhythmias, such as atrial fibrillation, in a single, easy-to-use chest patch. This can streamline the diagnostic process for patients with co-existing sleep and cardiac conditions, reducing the need for multiple separate tests. Physicians should note that while the device provides actionable ECG strips for cardiac insights, the ECG data requires manual annotation and analysis. It is a valuable tool for identifying cardiac comorbidities in sleep apnea patients and can aid in initiating guideline-directed care more efficiently. The device's simplicity and cellular data upload improve patient compliance and data reliability.

The SANSA device integrates multiple physiological sensors (PPG, single-lead ECG, accelerometer) into a single-point-of-contact patch, eliminating external wires or attachments. Its advanced signal processing and AI/ML components analyze the collected data to generate comprehensive reports. The latest iteration includes built-in cellular connectivity for automatic data upload, ensuring secure and near real-time transmission of results to the Huxley HUBu2122 portal for physician review, without requiring patient interaction with a smartphone or Bluetooth.

Details

Category Cardiology AI, Wearables & Remote Monitoring (RPM)
Pricing Contact for pricing
DeploymentCloud-based algorithm with cellular data upload from device
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Yes AI-estimated

Huxley Medical's SANSA Home Sleep Apnea Test (K240285) received 510(k) clearance from the FDA on July 15, 2024, for the recording, analysis, and storage of biophysical parameters to aid in the evaluation of sleep-related breathing disorders in adults suspected of sleep apnea. Subsequent clearances have expanded its capabilities to include diagnostic ECG monitoring for cardiac arrhythmias.

Integrations
EHR Not specified
Specialties Cardiology, Pulmonology, Sleep Medicine

What the Web Says

The Huxley SANSA Home Sleep Apnea Test (1000-00) is an FDA-cleared, chest-worn patch designed for at-home diagnosis of sleep apnea, including obstructive and central sleep apnea, and now also functions as a diagnostic ECG monitor for cardiac arrhythmias. It aims to simplify the testing process by consolidating multiple physiological monitoring channels into a single, wireless device, eliminating the need for numerous wires, belts, or smartphone apps. Clinical studies have shown its performance to be comparable to in-laboratory polysomnography (PSG), the gold standard for sleep apnea diagnosis.

Overall: Positive

Strengths

  • FDA-cleared for obstructive and central sleep apnea detection, and diagnostic ECG monitoring.
  • Single, chest-worn patch design simplifies application and improves patient comfort and compliance.
  • Wireless and uses cellular data upload, eliminating the need for multiple wires, tubing, or smartphone apps, and reducing connectivity issues.
  • Provides comprehensive data, measuring eight to nine physiological channels, including blood oxygen saturation, heart rate, respiratory effort, and sleep staging.
  • Demonstrated high accuracy, sensitivity, and specificity in detecting sleep apnea compared to in-lab PSG.
  • Effective performance across all skin tones, addressing a previous challenge in sleep testing devices.

Limitations

  • Some Reddit users expressed concern about the device being single-use and disposable, questioning the environmental impact and potential for waste.
  • While generally accurate, one Reddit user reported a home test showing no sleep apnea, but a subsequent in-lab study diagnosed severe sleep apnea.
  • The process can be impersonal for those desiring more interaction with a healthcare provider.
  • Specificity for detecting sleep apnea can decrease at lower AHI cutoffs.
  • Home sleep tests are generally only clinically appropriate for patients who meet specific pre-test criteria.
  • Automated algorithms process SANSA data without technologist review, unlike the manual scoring of PSG studies.

Based on reviews from: Huxley Medical (SANSA by Huxley), Patient Care Online, Frontiers in Neurology (via PMC - NIH), SleepWorld Magazine, Respiratory Therapy, Reddit, Xtalks, accessdata.fda.gov, DAIC, YouTube, Sleep Review (Home Sleep Test Devices Comparison Guide)

Last updated: 2026-07-18

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Huxley SANSA Home Sleep Apnea Test (1000-00)

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Innolitics
Huxley SANSA Home Sleep Apnea Test (1000-00) (K240285) u2014 FDA 510(k)
The Huxley SANSA Home Sleep Apnea Test (1000-00) received 510(k) clearance from the FDA on July 15, 2024, as a Class II medical device for the evaluation of sleep-related breathing disorders. It is a wearable device intended for clinical and home use under the direction of a healthcare professional.
2024-07
FDA
K240285 - 510(k) Premarket Notification - FDA
This FDA document details the 510(k) premarket notification for the Huxley SANSA Home Sleep Apnea Test (1000-00), submitted by Huxley Medical. It outlines the device's classification, product code, and the regulatory review process.
2026-04
FDA
Huxley SANSA Home Sleep Apnea Test (1000-00) | FDA Radiology...
The FDA lists the Huxley SANSA Home Sleep Apnea Test (1000-00) as a wearable device that records various physiological signals to aid in the evaluation of sleep-related breathing disorders.
2024-07
Physician AI Tools
Huxley SANSA Home Sleep Apnea Test (1000-00) vs ASSURE Wearable ECG
This comparison highlights the Huxley SANSA Home Sleep Apnea Test's innovative integration of multi-channel physiological data for both sleep apnea and cardiac arrhythmia diagnosis into a single, app-free, cellular-enabled chest patch, simplifying the diagnostic process.
unknown
PMC (PubMed Central)
Machine Learning-Enabled Medical Devices Authorized by the US Food and Drug Administration in 2024: Regulatory Characteristics, Predicate Lineage, and Transparency Reporting - PMC
The Huxley SANSA Home Sleep Apnea Test (1000-00) is listed as an AI-enabled medical device authorized by the FDA in 2024, cleared via the 510(k) pathway for obstructive sleep apnea diagnosis.
2025-12
OUCI
Emerging biosensor technologies for obstructive sleep apnea: A comprehensive overview and future prospects - OUCI
This book chapter references the Huxley SANSA Home Sleep Apnea Test (1000-00) 510(k) premarket notification from the FDA, indicating its relevance in the field of emerging biosensor technologies for obstructive sleep apnea.
2025
FDA.report
Ventilatory Effort Recorder MNR - FDA.report
The Huxley SANSA Home Sleep Apnea Test (1000-00) is listed under the Ventilatory Effort Recorder (MNR) product code, with its FDA clearance date of July 15, 2024.
unknown
FDA
TPLC - Total Product Life Cycle - FDA
The FDA's Total Product Life Cycle database includes the Huxley SANSA Home Sleep Apnea Test (1000-00) (K240285) among other devices, indicating its regulatory status and related information.
2026-06

Videos

Product demos, reviews, and walkthroughs for Huxley SANSA Home Sleep Apnea Test (1000-00).

Loading videos...

View all on YouTube

Frequently Asked Questions

The Huxley SANSA device employs advanced signal processing and artificial intelligence for automated scoring and sleep/wake classification, analyzing nine physiological data channels. Clinical trials have demonstrated high diagnostic accuracy, with 88% sensitivity and 87% specificity for detecting moderate-to-severe obstructive sleep apnea compared to in-lab polysomnography.
Physicians may be concerned about the comfort level with new AI technology, the need for external validation of AI algorithms, and the potential for bias if the training data is not representative of diverse patient populations. Huxley Medical emphasizes that SANSA is FDA-cleared and validated in a large, diverse clinical trial, aiming to build trust and ensure reliable performance across various patient demographics.
The SANSA device is designed as a comfortable, single chest-worn patch with an app-free workflow and built-in cellular data upload, aiming to improve patient compliance and ease of self-application. Its AI capabilities simplify the testing process by providing automated data analysis, reducing the burden on both patients and clinicians.
While PSG remains the gold standard, the AI-powered SANSA offers a more convenient and cost-effective alternative for diagnosing obstructive sleep apnea, providing comparable performance for various severity levels. Unlike many conventional home sleep tests, SANSA's AI and multi-channel data collection, including EKG, aim to offer a more comprehensive picture, though some traditional HSATs may have limitations in detecting accurate sleep stages or arousals.
Home sleep apnea tests generally range from $100 to $1,000, significantly less than in-lab PSG which can cost $1,000 to $10,000. As a prescription-use, FDA-cleared medical device, the cost of the Huxley SANSA is often covered by insurance if deemed medically necessary, though specific coverage depends on the patient's plan and deductible.
While highly accurate for OSA detection, the SANSA's AI-based sleep/wake classification has a lower specificity for sleep (63%) compared to its sensitivity (95%). Physicians should also be mindful that AI models are dependent on their training data, necessitating careful consideration of potential biases and the need for ongoing validation in diverse patient populations.

Related Tools

Cardiomatics
Cardiomatics
Cardiology AI
Cardiomatics is a cloud-based, AI-powered software for analyzing ambulatory (Holter) ECG tests, using clinically validated algorithms to provide accurate and high-quality results for cardiac diagnostics. It aims to streamline ECG analysis, reduce interpretation time, and improve diagnostic accuracy for various heart conditions.
SafeBeat Rx App
SafeBeat Rx, Inc.
Cardiology AI
An AI application designed to support safe pharmacological treatment and monitoring for cardiac arrhythmias.
PreemptiveAI Clinical SDK
Measure Labs, Inc. (Dba Preemptiveai, Inc.)
Cardiology AI
A clinical software development kit using AI to model and predict cardiovascular health metrics, aiming to shift healthcare from reactive to proactive by providing early health risk signals.
Clarius Ejection Fraction AI
Clarius Mobile Health Corp.
Cardiology AI
Clarius Ejection Fraction AI is an AI-powered ultrasound tool for automated left ventricular ejection fraction calculation, integrated into the Clarius Ultrasound App for real-time cardiac assessments.
Automated Aortic Stenosis Software (AutoAS)
Multiple companies are developing Automated Aortic Stenosis Software (AutoAS) or similar AI-powered solutions. Notable ones include iCardio.ai, Us2.ai, AccurKardia, HeartSciences Inc., and Echo IQ.
Cardiology AI
Automated Aortic Stenosis Software (AutoAS) is an ultrasound application by GE Medical Systems that provides automated assessment of aortic stenosis to enhance diagnostic efficiency and consistency.
ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm
Anumana
Cardiology AI
An AI algorithm that analyzes standard 12-lead ECG recordings to detect signs of pulmonary hypertension, aiming for earlier diagnosis and improved patient outcomes.

See all Cardiology AI tools →

More from Huxley Medical

SANSA HSAT
Huxley Medical
Neurology AI
Huxley Medical's SANSA HSAT is an FDA-cleared, AI-powered, app-free chest-worn diagnostic patch for home sleep apnea testing, providing streamlined diagnosis of Obstructive and Central Sleep Apnea by analyzing 9 physiological data channels.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.